We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+16.26%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$420M
AUM Growth
-$389M
(-48%)
Cap. Flow
-$446M
Cap. Flow
% of AUM
-106.34%
Top 10 Holdings %
Top 10 Hldgs %
28.19%
Holding
331
New
97
Increased
19
Reduced
68
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$9.2M |
| 2 |
AGN
Allergan Inc
AGN
|
+$8.12M |
| 3 |
DaVita
DVA
|
+$6.03M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$5.2M |
| 5 |
Cardinal Health
CAH
|
+$4.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPG Industries
PPG
|
+$15.6M |
| 2 |
Danaher
DHR
|
+$13.7M |
| 3 |
Estee Lauder
EL
|
+$13M |
| 4 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$12M |
| 5 |
ITT
ITT
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.96% |
| 2 | Industrials | 11.78% |
| 3 | Consumer Discretionary | 8.25% |
| 4 | Communication Services | 5.77% |
| 5 | Consumer Staples | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LIFE
1
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $22.7M | 5.41% |
299,600
-50,400
| -14% | -$3.8M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $16.4M | 3.91% |
97,781
+30,696
| +46% | +$4.8M |
|
3
PUT
Invesco QQQ Trust
QQQ
$450B
| $13.2M | 3.14% |
+150,000
| New | +$12.5M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $12.7M | 3.03% |
90,000
+70,000
| +350% | +$9.2M |
|
5
Zimmer Biomet
ZBH
$18.4B
| $9.6M | 2.29% |
106,074
+10,097
| +11% | +$874K |
|
|
AGN
6
DELISTED
Allergan Inc
AGN
| $9.44M | 2.25% |
+85,000
| New | +$8.12M |
|
7
McKesson
MCK
$101B
| $8.88M | 2.12% |
55,000
+15,000
| +38% | +$2.3M |
|
|
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
| $8.54M | 2.04% |
278,261
+183,817
| +195% | +$5.2M |
|
9
Perrigo
PRGO
$1.43B
| $8.44M | 2.01% |
55,000
+15,000
| +38% | +$2.16M |
|
|
AGN
10
PUT
DELISTED
Allergan Inc
AGN
| $8.33M | 1.99% |
+75,000
| New | +$7.16M |
|
11
CALL
Teva Pharmaceuticals
TEVA
$41.2B
| $8.02M | 1.91% |
+200,000
| New | +$7.88M |
|
12
Viatris
VTRS
$20.7B
| $7.59M | 1.81% |
175,000
+40,000
| +30% | +$1.64M |
|
|
SPNC
13
DELISTED
Spectranetics Corp
SPNC
| $6.88M | 1.64% |
275,000
+156,702
| +132% | +$3.36M |
|
|
JAH
14
DELISTED
JARDEN CORPORATION
JAH
| $6.81M | 1.62% |
166,490
-276,750
| -62% | -$10M |
|
|
HUB.B
15
DELISTED
HUBBELL INC CL-B
HUB.B
| $6.73M | 1.6% |
61,773
-24,024
| -28% | -$2.57M |
|
|
16
DaVita
DVA
$15.3B
| $6.51M | 1.55% |
+102,677
| New | +$6.03M |
|
17
Universal Health Services
UHS
$9.88B
| $6.09M | 1.45% |
75,000
+5,000
| +7% | +$399K |
|
18
Jazz Pharmaceuticals
JAZZ
$16.2B
| $5.7M | 1.36% |
+45,000
| New | +$4.66M |
|
19
Illumina
ILMN
$31B
| $5.53M | 1.32% |
+51,400
| New | +$4.71M |
|
|
20
PUT
Illumina
ILMN
$31B
| $5.53M | 1.32% |
+51,400
| New | +$4.71M |
|
21
PUT
Bristol-Myers Squibb
BMY
$132B
| $5.32M | 1.27% |
+100,000
| New | +$5.09M |
|
|
22
Cardinal Health
CAH
$53.2B
| $5.29M | 1.26% |
+79,136
| New | +$4.84M |
|
|
PARA
23
DELISTED
Paramount Global Class B
PARA
| $5.11M | 1.22% |
80,131
-9,635
| -11% | -$567K |
|
24
3M
MMM
$90.8B
| $4.67M | 1.11% |
39,818
+35,755
| +880% | +$3.81M |
|
|
25
Bristol-Myers Squibb
BMY
$132B
| $4.52M | 1.08% |
+85,000
| New | +$4.33M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Catapult Capital Management held 331 positions worth $420M, down 48% from $809M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Catapult Capital Management withdrew a net $446M in Q4 2013, closing 147 positions and reducing 68 holdings. Its most notable exit was Estee Lauder, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Catapult Capital Management opened a new position in Allergan Inc worth $9.44M.
- Catapult Capital Management's largest Q4 2013 buy was Allergan Inc: 85,000 shares worth $9.44M.
- Catapult Capital Management added most to Shire pic in Q4 2013, an estimated $9.2M increase.
- Catapult Capital Management's biggest Q4 2013 reduction was PPG Industries, cutting an estimated $15.6M.
- Catapult Capital Management fully exited Estee Lauder in Q4 2013, selling an estimated $13M.
- Catapult Capital Management's ten largest holdings make up 28% of its $420M portfolio in Q4 2013.
- Catapult Capital Management opened 97 new positions and closed 147 in Q4 2013.
- Catapult Capital Management's portfolio value fell 48% quarter-over-quarter to $420M.
Based on Catapult Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.